First in Man Study of the JenaValve TAVI Plus System Transfemoral

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2015

Conditions
Aortic Valve StenosisHeart Valve DiseasesHeart DiseasesCardiovascular Diseases
Interventions
DEVICE

JenaValve Pericardial TAVR System

The JenaValve Pericardial TAVI system is intended for use in subjects with symptomatic severe aortic stenosis who are at high risk for surgical aortic valve replacement.

Trial Locations (2)

20251

University of Hamburg Medical Center, Hamburg

50937

University of Koln Medical Center, Cologne

Sponsors
All Listed Sponsors
lead

JenaValve Technology, Inc.

INDUSTRY

NCT02818959 - First in Man Study of the JenaValve TAVI Plus System Transfemoral | Biotech Hunter | Biotech Hunter